VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
WGRXWellgistics Health, Inc.
$3.10$8M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksWGRXEarnings History

WGRX logoWellgistics Health, Inc. (WGRX) Earnings History

Net Loss

3 years of earnings data (2023–2025) · Currently unprofitable on a TTM basis

TTM Net Income
-$77M
● Net Loss
TTM EPS (Diluted)
$-53.94
Per share, diluted
YoY EPS Growth
-1000.0%
Declining
Net Margin
-433.9%
After-tax profitability
EPS Growth Rate (CAGR)
1YN/A
3YN/A
5YN/A
10YN/A
Operating Margin-347.9%
Gross Margin-41.3%
Return on EquityN/A
Return on Assets-230.7%
Record Annual Net Income-$3MFY2023
Record Quarterly EPS$-0.56Q2 2024
Consecutive Profitable Years0years
Q1 2026
Net Income-$8M
EPS (Diluted)$-3.50
YoY Growth-1000.0%Declining
QoQ Growth+72.2%Excellent

Loading earnings history...

Wellgistics Health, Inc. (WGRX) Earnings Overview

As of June 23, 2026, Wellgistics Health, Inc. (WGRX) reported trailing twelve-month net income of -$77M, reflecting -1000.0% year-over-year growth. The company earned $-53.94 per diluted share over the past four quarters, with a net profit margin of -433.9%.

Looking at the long-term picture, WGRX's historical earnings data spans multiple years. The company achieved its highest annual net income of -$3M in fiscal 2023.

Wellgistics Health, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →

Compared to peers including HSIC ($398M net income, 3.0% margin), OMI (-$1.10B net income, -39.8% margin), HCSG ($59M net income, 3.2% margin), WGRX has room to improve margins relative to the peer group. Compare WGRX vs HSIC →

WGRX Earnings vs Peers

Earnings metrics vs comparable public companies

CompanyTTM Net IncomeTTM EPSNet MarginROEYoY GrowthCompare
WGRX logoWGRXCurrent
-$77M$-53.94-433.9%--1000.0%—
HSIC logoHSIC
$398M$3.363.0%8.3%+7.2%
OMI logoOMI
-$1.1B$-14.24-39.8%-2111.6%-201.1%
HCSG logoHCSG
$59M$0.823.2%11.7%+52.8%
MCK logoMCK
$4.8B$38.811.2%-+49.2%
CAH logoCAH
$1.6B$6.610.7%-+87.0%
Best in group
Lowest in group

WGRX Historical Earnings Data (2023–2025)

3 years
Fiscal Year Net Income YoY % Operating Income EPS (Diluted) Net Margin Op. Margin
2025-$101M-1377.1%-$81M$-71.50-433.9%-347.9%
2024-$7M-136.8%-$6M$-6.50-37.8%-33.9%
2023-$3M--$3M$-3.00--

Download Data

Export WGRX earnings history in CSV or JSON format

Free sign-in required to download data

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

3+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

WGRX — Frequently Asked Questions

Quick answers to the most common questions about buying WGRX stock.

What is WGRX earnings per share (EPS)?

WGRX trailing twelve-month (TTM) diluted EPS is $-53.94, reflecting -1000.0% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2023 to 2025 is available in the table on this page.

What is Wellgistics Health, Inc.'s net income?

Wellgistics Health, Inc. (WGRX) trailing twelve-month net income is $-77M as of 2025. Earnings declined -1000.0% year-over-year.

Is WGRX profitable?

WGRX is not currently profitable on a TTM basis, reporting a net loss of $-77M. Net margin is -433.9%. Investors should monitor for a return to profitability.

What is WGRX's earnings growth rate?

WGRX compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2023 to 2025.

What are WGRX's profit margins?

Wellgistics Health, Inc. net profit margin is -433.9%, operating margin is -347.9%, and gross margin is -41.3%. Below-average margins reflect competitive or cost pressures. Return on Equity is N/A.

Is WGRX growing earnings?

WGRX earnings are declining — EPS fell -1000.0% year-over-year. TTM net income dropped to $-77M. This contrasts with the 5-year CAGR of N/A.

What was WGRX's best earnings year?

Wellgistics Health, Inc.'s highest annual net income on record is $-3M, achieved in fiscal year 2023. Earnings history on this page spans 2023 to 2025 and includes all annual and quarterly figures.

What were WGRX's earnings last quarter?

WGRX's most recent reported quarter was Q1 2026. Net income was $-8M with diluted EPS of $-3.50. For a full breakdown of all quarters, see the quarterly earnings table on this page.

WGRX Earnings Over Time (2023–2025)

Net income & EPS — annual and quarterly view